A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia-Reference-Cited by-同舟云学术

A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia

Published:2023-07 Issue:4 Volume:23 Page:441-454
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Kim Min Chul,Ahn Youngkeun,Kim Moo Hyun,Kim Seok-Yeon,Hong Taek Jong,Rhee Moo-Yong,Kim Sang-Hyun,Hong Soon-Jun,Kim Hyungseop,Kim Weon,Chae In Ho,Kang Duk-hyun,Kim Byeong-Keuk,Kim Hyo-Soo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40256-023-00590-9.pdf

Reference46 articles.

1. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76:2982–3021.

2. Wong ND, Lopez V, Tang S, Williams GR. Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States. Am J Cardiol. 2006;98:204–8.

3. Yokoyama H, Oishi M, Takamura H, Yamasaki K, Shirabe SI, Uchida D, et al. Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40). BMJ Open Diabetes Res Care. 2016;4: e000294.

4. Yan X, Li Y, Dong Y, Wu Y, Li J, Bian R, et al. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy. Lipids Health Dis. 2019;18:32.

5. Trimarco V, Izzo R, Morisco C, Mone P, Virginia Manzi M, et al. High HDL (High-Density Lipoprotein) cholesterol increases cardiovascular risk in hypertensive patients. Hypertension. 2022;79:2355–63.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of dyslipidemia and hyperhomocysteinemia on the development of arterial hypertension;Galenika Medical Journal;2024